However, the pace of increase is slowing compared to previous years.
These numbers contribute to an estimated 2. Just over half of those diagnosed in the Region are diagnosed at a late stage of infection. Countries of the Region have made progress towards achieving universal access to HIV prevention, testing, treatment, care and support.
Nevertheless, the response to HIV faces hiv and liver cancer challenges. HIV status and late diagnosis Due to inadequate levels of access to and slow uptake of voluntary HIV testing and counselling in many countries — especially among key populations at higher risk of HIV infection — many people living with HIV in the Region remain undiagnosed.
As a consequence, these individuals do not receive the lifesaving antiretroviral treatment ART they need to suppress the virus enough to prevent onward transmission. One fifth of people living with HIV in the Region are estimated to be unaware of their infection.
Late treatment initiation For HIV treatment to work effectively, it should be started as soon as possible following a positive HIV diagnosis.
Unfortunately, hiv and liver cancer people living with HIV in the Region initiate treatment too late, and present with symptoms of widespread immune system damage at the hiv and liver cancer of ART initiation. Delayed treatment initiation can also lead to the spread of HIV infection to others, since the virus is not suppressed and can still be transmitted.
Low access to treatment Access hiv and liver cancer HIV treatment is low in a number of countries, notably in the eastern part the Region.
Low access to treatment and care, fear of discrimination, and stigmatization collectively reduce the incentive to take an HIV test. Coinfection can lead to life-threatening liver failure.
Hepatitis is difficult and costly to treat, and this situation is likely to lead to tens of thousands of preventable deaths in the years to come.